Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law The peptide problem: Hype is outrunning the evidence An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences